Product Information
POTASSIUM CL ER 8 MEQ TABLET is a generic product labeled by Epic Pharma LLC, priced at $0.1028 per EA under NDC 42806042205. Its NADAC has been published 134 times since Mar 13, 2024.
FDA first approved this application on Jun 22, 2018. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
600 mg/1
Manufacturer
Epic Pharma LLCNDC
42806042205
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209314FDA Approved
6/22/2018
TE Code
AB2
On Market Since
8/7/2023
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 8 MEQ TABLET has been published 134 times since Mar 13, 2024, and over the history we have for it it has declined 28.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1028 per EA |
|---|---|
| All-time high | $0.1745 (Apr 10, 2024) |
| All-time low | $0.1020 (Aug 19, 2026) |
| 52-week high | $0.1411 |
| 52-week low | $0.1020 |
| Median price | $0.1282 |
| Average price | $0.1283 |
| Largest weekly change | -39.3% (Apr 17, 2024) |
| Weeks tracked | 134 |
| Tracking since | Mar 13, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Epic Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Potassium Chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 8 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 8 MEQ TABLET, manufactured by Epic Pharma LLC, is $0.1028 per EA (NDC 42806042205), effective Sep 30, 2026.
How has the price of POTASSIUM CL ER 8 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has declined 28.8%. It has been tracked across 134 weekly CMS publications since Mar 13, 2024.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 8 MEQ TABLET?
Since Mar 13, 2024, the NADAC for POTASSIUM CL ER 8 MEQ TABLET has ranged from a low of $0.1020 (Aug 19, 2026) to a high of $0.1745 (Apr 10, 2024), with a median of $0.1282 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 8 MEQ TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 8 MEQ TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures POTASSIUM CL ER 8 MEQ TABLET?
POTASSIUM CL ER 8 MEQ TABLET (NDC 42806042205) is labeled by Epic Pharma LLC, and CMS classifies it as a generic product.